Inducing ICD in tumor cells can lead to improvements in the tumor microenvironment [22], increased secretion of type I interferons [23], upregulated CRT expression on tumor cell surfaces [24], enhanced tumor immunogenicity [25] and effectively activate antitumor immunity. The gene discussed is CALR; the disease is neoplasm.